6005 ORAL A Multicenter, Randomized, Double-blind, Phase II Study of TAS-102 (A) Plus Best Supportive Care (BSC) Versus Placebo (P) Plus BSC in Patients (pts) With Chemotherapy-refractory Metastatic Colorectal Cancer (mCRC)

✍ Scribed by Kuboki, Y.; Yoshino, T.; Yamazaki, K.; Nishina, T.; Komatsu, Y.; Baba, H.; Tsuji, A.; Yamaguchi, K.; Muro, K.; Ohtsu, A.

• Book ID: 122773219
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 42 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71650-1